Llwytho...
Ascorbic acid: a promising agent in chronic kidney disease?
Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, is related with impaired endothelial function and poor outcomes in chronic kidney disease (CKD) patients. In addition, oxidative stress and inflammation are also a common problem in CKD patients, and both have an impo...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Clin Kidney J |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6070088/ https://ncbi.nlm.nih.gov/pubmed/30094017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfy044 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|